scispace - formally typeset
L

Lingling Shan

Researcher at National Institutes of Health

Publications -  19
Citations -  1005

Lingling Shan is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Photothermal therapy & Arthritis. The author has an hindex of 13, co-authored 17 publications receiving 690 citations. Previous affiliations of Lingling Shan include Soochow University (Suzhou).

Papers
More filters
Journal ArticleDOI

Organic Semiconducting Photoacoustic Nanodroplets for Laser-Activatable Ultrasound Imaging and Combinational Cancer Therapy.

TL;DR: The PS-PDI-PAnDs represents a type of PFC nanodroplets for synergistic PDT/PTT treatment upon a single laser irradiation, which is expected to hold great potential in the clinical translation in dual-modal PA/US imaging-guided combinational cancer therapy.
Journal ArticleDOI

Near‐Infrared Semiconducting Polymer Brush and pH/GSH‐Responsive Polyoxometalate Cluster Hybrid Platform for Enhanced Tumor‐Specific Phototheranostics

TL;DR: The smart pH/glutathione (GSH)-responsive SPB@POM allows for remarkablePhototheranostic enhancement under the unique TME, which has potential for precise tumor-specific phototheranostics with minimal side effects.
Journal ArticleDOI

Generic synthesis of small-sized hollow mesoporous organosilica nanoparticles for oxygen-independent X-ray-activated synergistic therapy.

TL;DR: An ammonia-assisted hot water etching strategy for the generic synthesis of a library of small-sized hollow mesoporous organosilica nanoparticles with mono, double, triple, and even quadruple framework hybridization of diverse organic moieties designed for oxygen-independent X-ray-activated synergistic therapy.
Journal ArticleDOI

Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy.

TL;DR: An "ammonia-assisted hot water etching" method is applied for the successful construction of sub-50 nm thioether/phenylene dual-hybridized HMON with low hemolytic effect and holds significant potential in realizing TME-responsive self-assembly for enhanced tumor accumulation and precise tumor-specific synergistic therapy, which is very promising for clinical translation.